Sonnet Biotherapeutics Holdings Inc. buy Chardan Capital
Start price
16.08.23
/
50%
€0.38
Target price
16.08.24
€11.00
Performance (%)
-51.06%
End price
17.08.24
-
Summary
This prediction is currently being closed. Massive losses of -51.06% have been the result for the BUY prediction by Chardan_Capital. Chardan_Capital has a follow-up prediction for Sonnet Biotherapeutics Holdings Inc. where he still thinks Sonnet Biotherapeutics Holdings Inc. is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Sonnet Biotherapeutics Holdings Inc. | - | - | - |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by Chardan_Capital for this prediction
In the thread Sonnet Biotherapeutics Hldgs. Inc. diskutieren
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) had its price target lowered by analysts at Chardan Capital from $14.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for SONN provided by MarketBeat
In the thread Trading Sonnet Biotherapeutics Hldgs. Inc.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for Sonnet Biotherapeutics Holdings Inc.
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
15.02.24
15.02.24
€27.86
15.02.25
15.02.25
-
20.11.23
20.11.23
Stopped prediction by Chardan_Capital for Sonnet Biotherapeutics Holdings Inc.
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
23.08.24
23.08.24
€26.85
23.08.25
23.08.25
-
20.11.23
20.11.23
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
28.05.24
28.05.24
€27.57
28.05.25
28.05.25
-
20.11.23
20.11.23